2015-2016 Seminars

September 30, 2015
Title: Targeting Breast Cancer Stem Cells as Novel Cancer Prevention Approaches
Speaker: Nanjoo Suh, Ph.D., Professor, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University

November 4, 2015
Title: The Flexible DNA Replication Landscape Facilitating Genomic Stability
Speaker: Mirit Aladjem, Ph.D., Senior Investigator, Head, DNA replication Group, Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH

November 6, 2015
Title: Targeting CDK4/6 in Human Cancer: Mechanism and Therapies
Speaker: Selina Chen-Kiang, Ph.D., Professor of Pathology, Professor of Immunobiology and Microbial Pathogenesis, Mayer Cancer Center at Weill Cornell Medical College

December 2, 2015
Title: Proteomics for Individual Therapy of Cancer
Speaker: Lance A. Liotta, M.D., Ph.D., University Professor, Co-Director Center for Applied Proteomics and Molecular Medicine, George Mason University

January 20, 2016
Title: Functions, Mechanisms and Therapeutic Potential of Chromatin
Speaker: Gerd Blobel, M.D., Ph.D., Frank E. Weise III Professor of Pediatrics, The Children’s Hospital of Philadelphia, Co-Director U-Penn Epigenetic Program, University of Pennsylvania

February 24, 2016
Title:Protein Complexes and Ubiquitylation Regulates Base Excision Repair Protein Stability
Speaker: Robert Sobol, Ph.D., Point Clear Charities Professor of Oncologic Sciences, Chief, Molecular & Metabolic Oncology Program, Abraham A. Mitchell Distinguished Investigator, University of South Alabama Mitchell Cancer Institute

March 9, 2016
Title: A Novel Mechanism of Epidermal Cancer Stem Cell Driven Angiogenesis
Speaker: Richard L. Eckert, Ph.D., John F.B. Weaver Distinguished Professor, Chair – Department of Biochemistry and Molecular Biology, Associate Director – Basic Sciences Greenbaum Cancer Center, University of Maryland School of Medicine

May 11, 2016
Title: Toward Personalized Oncology: Functional Testing of Patient Derived Tumor Cells to Identify Novel Drug
Speaker: Christopher Kemp, Ph.D., Member, Human Biology Division, Member, Public Health Sciences Division, Translational research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington